Table 4.

Association between sex and primary and secondary outcomes: Overlap propensity score-weighted average treatment effect among the overlap population (ATO)

	ATO (95% CI)	p value
Primary outcomes
PGD3 at T48	− 0.143 (− 0.290, − 0.028)	0.055
PGD3 at T72	− 0.065 (− 0.204, 0.075)	0.365
PGD decrease from T0 to T72	0.193 (0.048, 0.337)	0.009
PGD difference from T72 to T0	− 0.319 (− 0.631, − 0.007)	0.045
Secondary outcomes
Postoperative bacteremia	0.072 (− 0.063, 0.207)	0.295
Postoperative wound infection	0.020 (− 0.054, 0.094)	0.601
C. difficile colitis	0.055 (− 0.014, 0.124)	0.119
90-d survival	0.042 (− 0.017, 0.100)	0.164
1-y survival	0.040 (− 0.093, 0.172)	0.555
Peak lactate within 72 h, mg/dL	− 1.565 (− 2.622, − 0.509)	0.004
Stroke	0.007 (− 0.066, 0.080)	0.854
Acute rejection during hospitalization	− 0.052 (− 0.162, 0.059)	0.362
ICU LOS, d	3.249 (− 4.766, 11.263)	0.427
Tracheostomy	0.126 (− 0.013, 0.265)	0.075
Airway dehiscence	− 0.012 (− 0.072, 0.049)	0.703
Mechanical ventilation ≥ 5 d	0.130 (− 0.010, 0.270)	0.069
Postoperative ECMO	− 0.038 (− 0.149, 0.074)	0.507
Readmission within 1 y	− 0.029 (− 0.140, 0.082)	0.607

Data reported as ATO (95% CI). 95% CI not including 0 indicates a statistically significant difference in secondary outcome between men and women

ECMO extracorporeal membrane oxygenation, ICU intensive care unit, LOS length of stay, PGD primary graft dysfunction